We also analyzed the ILK1 expression levels in patients with glioblastomas, astrocytomas and oligodendrogliomas and found that high levels of ILK1 expression correlate with poor prognosis. This evidence concerns the gene ILK and astrocytoma (excluding glioblastoma).